Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
rapamycin (3 trials)
Adenomatous Polyposis Coli (Phase 2)
Colorectal Neoplasms (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (1 total)